Abbott Labs’ surprise guidance bump is a major positive for its shareholders

Earnings

An Abbott Labs employee gets the BinaxNOW rapid Covid-19 antigen test at her workplace.
Abbott Labs

Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016.

Articles You May Like

There’s a ‘compressed timeline’ to submit a FAFSA form this year — Here’s how to prepare
Will you have a lower tax rate in retirement? Maybe not, financial advisors say
Wake Up: It’s Time To Check Out Your 2025 Part D Drug Coverage
Yields on cash are still ‘well ahead of inflation,’ expert says. Here’s where to put your money now
Family offices becoming ‘economic powerhouse’ in private company deals

Leave a Reply

Your email address will not be published. Required fields are marked *